Corcept Therapeutics | CORT - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Alaunos Therapeutics USD 354K 1.03M 2026-03
ANI Pharmaceuticals USD 360.21M 49.04M 2026-06
Ardelyx USD 31.21M 36.79M 2026-03
Aurora Cannabis CAD 64.69M 8.33M 2026-03
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Canopy Growth CAD 364.68M 6.64M 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Eli Lilly USD 8.95B 3.67B 2026-06
J&J USD 20.42B 1.27B 2026-06
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
Merck USD 6.85B 1.52B 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Novartis USD 7.62B 739M 2026-06
Novartis USD 6.88B 2.68B 2026-03
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 205.88M 61.57M 2026-06
Pfizer USD 976M 727M 2026-06
Supernus Pharmaceuticals USD 179.95M 4.92M 2026-06
TG Therapeutics USD 612.25M 170.04M 2026-06